The new discipline of oculomics uses machine learning to detect biomarkers of systemic health in the eye. Kim Thomas asks: how does it work, what are its ethical implications, and will it be the future of the profession?

Our Clinical Adviser comments on a new study that small increases in air pollution are linked to an increased risk of AMD.

Podcast: Martin and Daniel bring you a fascinating conversation with Judith Potts, Founder of Esme's Umbrella, and Nina Chesworth who lives with Charles Bonnet Syndrome.

This article outlines the clinical implications for patients affected by impaired face perception.


Becky McCall looks at how the latest research has linked air pollution with eye health, and the advice to give patients on how to protect themselves.

A glance at what’s happening in the world of technology.

In our latest podcast, we speak to Professor Gilmartin and Mr Kam Balaggan, Consultant Ophthalmologist, about the battle to save his remaining vision.


Podcast: Professor Bernard Gilmartin FCOptom has very severe macular degeneration which has resulted in a dramatic loss of vision in one eye and threatens the vision in his other.


We asked five industry experts to round up the optical successes of 2018, and what they predict for the year ahead.

The floodgates have opened for a new era of gene therapy that can treat the inherited causes of eye disease. Becky McCall reports.


The College of Optometrists held its seventh Optometry Tomorrow Bitesize conference at the weekend.

Podcast: In this episode, Daniel talks to Jane Johns, a retired health visitor living with age-related macular degeneration (AMD), and Vanessa Camp, a Senior Eye Clinic Liaison Officer at York Hospital Trust.


Podcast: Martin talks to Professor Pete Coffey about the 'London Project to cure Blindness'.


In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.

We speak to Professor John Lawrenson FCOptom about his role authoring and reviewing the College’s Clinical Management Guidelines.

Dr David Robert Grimes looks at the eye health issues that are making the news.

The highlights from last weekend’s conference, including talks on OCT angiography and the future of glaucoma surgery.

The clinical figures that count.

What's happening in the world of technology.

Our Clinical Adviser comments on the story in the BBC about the woman who had gene therapy to try to halt the progression of age-related macular degeneration (AMD).

Our Clinical Adviser offers his advice, following an article by The Express on the best supplements for eyes.

Dr David Robert Grimes looks at the eye health issues that are making the news.